SrasV1, Ncbi, Merge, bibRecord, 001222

Synthesis and activity of an octapeptide inhibitor designed for SARS coronavirus main proteinase.

Identifieur interne : 001222 ( Ncbi/Merge ); précédent : 001221; suivant : 001223

Synthesis and activity of an octapeptide inhibitor designed for SARS coronavirus main proteinase.

Auteurs : Yi-Ru Gan [République populaire de Chine] ; He Huang ; Yong-Dong Huang ; Chun-Ming Rao ; Yang Zhao ; Jin-Sheng Liu ; Lei Wu ; Dong-Qing Wei

Source :

Peptides [ 0196-9781 ] ; 2006.

RBID : pubmed:16242214

Descripteurs français

KwdFr :
- Animaux, Antienzymes (), Antienzymes (pharmacologie), Antienzymes (synthèse chimique), Antiviraux (), Antiviraux (métabolisme), Cellules Vero, Cysteine endopeptidases (métabolisme), Données de séquences moléculaires, Oligopeptides (), Oligopeptides (pharmacologie), Oligopeptides (synthèse chimique), Protéines virales (antagonistes et inhibiteurs), Protéines virales (métabolisme), Séquence d'acides aminés, Virus du SRAS (), Virus du SRAS (enzymologie).
MESH :
- antagonistes et inhibiteurs : Protéines virales.
- enzymologie : Virus du SRAS.
- métabolisme : Antiviraux, Cysteine endopeptidases, Protéines virales.
- pharmacologie : Antienzymes, Oligopeptides.
- synthèse chimique : Antienzymes, Oligopeptides.
- Animaux, Antienzymes, Antiviraux, Cellules Vero, Données de séquences moléculaires, Oligopeptides, Séquence d'acides aminés, Virus du SRAS.

English descriptors

KwdEn :
- Amino Acid Sequence, Animals, Antiviral Agents (chemistry), Antiviral Agents (metabolism), Chlorocebus aethiops, Cysteine Endopeptidases (metabolism), Enzyme Inhibitors (chemical synthesis), Enzyme Inhibitors (chemistry), Enzyme Inhibitors (pharmacology), Molecular Sequence Data, Oligopeptides (chemical synthesis), Oligopeptides (chemistry), Oligopeptides (pharmacology), SARS Virus (drug effects), SARS Virus (enzymology), Vero Cells, Viral Proteins (antagonists & inhibitors), Viral Proteins (metabolism).
MESH :
- chemical , antagonists & inhibitors : Viral Proteins.
- chemical , chemical synthesis : Enzyme Inhibitors, Oligopeptides.
- chemical , chemistry : Antiviral Agents, Enzyme Inhibitors, Oligopeptides.
- chemical , metabolism : Antiviral Agents, Cysteine Endopeptidases, Viral Proteins.
- chemical , pharmacology : Enzyme Inhibitors, Oligopeptides.
- drug effects : SARS Virus.
- enzymology : SARS Virus.
- Amino Acid Sequence, Animals, Chlorocebus aethiops, Molecular Sequence Data, Vero Cells.

Abstract

The outbreak of SARS, a life-threatening disease, has spread over many countries around the world. So far there is no effective drug for the treatment of SARS. Stimulated by the binding mechanism of SARS-CoV Mpro with the octapeptide AVLQSGFR reported recently as well as the "Chou's distorted key" theory, we synthesized the octapeptide AVLQSGFR for conducting various biochemical experiments to investigate the antiviral potential of the octapeptide against SARS coronavirus (BJ-01). The results demonstrate that, compared with other compounds reported so far, AVLQSGFR is the most active in inhibiting replication of the SARS coronavirus, and that no detectable toxicity is observed on Vero cells under the condition of experimental concentration.

DOI: 10.1016/j.peptides.2005.09.006
PubMed: 16242214

Links toward previous steps (curation, corpus...)

to stream PubMed, to step Corpus: 002484
to stream PubMed, to step Curation: 002484
to stream PubMed, to step Checkpoint: 001F70

Links to Exploration step

pubmed:16242214

Le document en format XML

<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Synthesis and activity of an octapeptide inhibitor designed for SARS coronavirus main proteinase.</title>
<author><name sortKey="Gan, Yi Ru" sort="Gan, Yi Ru" uniqKey="Gan Y" first="Yi-Ru" last="Gan">Yi-Ru Gan</name>
<affiliation wicri:level="1"><nlm:affiliation>School of Chemical Engineering & Technology, Tianjin University, Tianjin 300072, China. lifescience@san.rr.com</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>School of Chemical Engineering & Technology, Tianjin University, Tianjin 300072</wicri:regionArea>
<placeName><settlement type="city">Tianjin</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Huang, He" sort="Huang, He" uniqKey="Huang H" first="He" last="Huang">He Huang</name>
</author>
<author><name sortKey="Huang, Yong Dong" sort="Huang, Yong Dong" uniqKey="Huang Y" first="Yong-Dong" last="Huang">Yong-Dong Huang</name>
</author>
<author><name sortKey="Rao, Chun Ming" sort="Rao, Chun Ming" uniqKey="Rao C" first="Chun-Ming" last="Rao">Chun-Ming Rao</name>
</author>
<author><name sortKey="Zhao, Yang" sort="Zhao, Yang" uniqKey="Zhao Y" first="Yang" last="Zhao">Yang Zhao</name>
</author>
<author><name sortKey="Liu, Jin Sheng" sort="Liu, Jin Sheng" uniqKey="Liu J" first="Jin-Sheng" last="Liu">Jin-Sheng Liu</name>
</author>
<author><name sortKey="Wu, Lei" sort="Wu, Lei" uniqKey="Wu L" first="Lei" last="Wu">Lei Wu</name>
</author>
<author><name sortKey="Wei, Dong Qing" sort="Wei, Dong Qing" uniqKey="Wei D" first="Dong-Qing" last="Wei">Dong-Qing Wei</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2006">2006</date>
<idno type="RBID">pubmed:16242214</idno>
<idno type="pmid">16242214</idno>
<idno type="doi">10.1016/j.peptides.2005.09.006</idno>
<idno type="wicri:Area/PubMed/Corpus">002484</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002484</idno>
<idno type="wicri:Area/PubMed/Curation">002484</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002484</idno>
<idno type="wicri:Area/PubMed/Checkpoint">001F70</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001F70</idno>
<idno type="wicri:Area/Ncbi/Merge">001222</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Synthesis and activity of an octapeptide inhibitor designed for SARS coronavirus main proteinase.</title>
<author><name sortKey="Gan, Yi Ru" sort="Gan, Yi Ru" uniqKey="Gan Y" first="Yi-Ru" last="Gan">Yi-Ru Gan</name>
<affiliation wicri:level="1"><nlm:affiliation>School of Chemical Engineering & Technology, Tianjin University, Tianjin 300072, China. lifescience@san.rr.com</nlm:affiliation>
<country xml:lang="fr">République populaire de Chine</country>
<wicri:regionArea>School of Chemical Engineering & Technology, Tianjin University, Tianjin 300072</wicri:regionArea>
<placeName><settlement type="city">Tianjin</settlement>
</placeName>
</affiliation>
</author>
<author><name sortKey="Huang, He" sort="Huang, He" uniqKey="Huang H" first="He" last="Huang">He Huang</name>
</author>
<author><name sortKey="Huang, Yong Dong" sort="Huang, Yong Dong" uniqKey="Huang Y" first="Yong-Dong" last="Huang">Yong-Dong Huang</name>
</author>
<author><name sortKey="Rao, Chun Ming" sort="Rao, Chun Ming" uniqKey="Rao C" first="Chun-Ming" last="Rao">Chun-Ming Rao</name>
</author>
<author><name sortKey="Zhao, Yang" sort="Zhao, Yang" uniqKey="Zhao Y" first="Yang" last="Zhao">Yang Zhao</name>
</author>
<author><name sortKey="Liu, Jin Sheng" sort="Liu, Jin Sheng" uniqKey="Liu J" first="Jin-Sheng" last="Liu">Jin-Sheng Liu</name>
</author>
<author><name sortKey="Wu, Lei" sort="Wu, Lei" uniqKey="Wu L" first="Lei" last="Wu">Lei Wu</name>
</author>
<author><name sortKey="Wei, Dong Qing" sort="Wei, Dong Qing" uniqKey="Wei D" first="Dong-Qing" last="Wei">Dong-Qing Wei</name>
</author>
</analytic>
<series><title level="j">Peptides</title>
<idno type="ISSN">0196-9781</idno>
<imprint><date when="2006" type="published">2006</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Amino Acid Sequence</term>
<term>Animals</term>
<term>Antiviral Agents (chemistry)</term>
<term>Antiviral Agents (metabolism)</term>
<term>Chlorocebus aethiops</term>
<term>Cysteine Endopeptidases (metabolism)</term>
<term>Enzyme Inhibitors (chemical synthesis)</term>
<term>Enzyme Inhibitors (chemistry)</term>
<term>Enzyme Inhibitors (pharmacology)</term>
<term>Molecular Sequence Data</term>
<term>Oligopeptides (chemical synthesis)</term>
<term>Oligopeptides (chemistry)</term>
<term>Oligopeptides (pharmacology)</term>
<term>SARS Virus (drug effects)</term>
<term>SARS Virus (enzymology)</term>
<term>Vero Cells</term>
<term>Viral Proteins (antagonists & inhibitors)</term>
<term>Viral Proteins (metabolism)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Animaux</term>
<term>Antienzymes ()</term>
<term>Antienzymes (pharmacologie)</term>
<term>Antienzymes (synthèse chimique)</term>
<term>Antiviraux ()</term>
<term>Antiviraux (métabolisme)</term>
<term>Cellules Vero</term>
<term>Cysteine endopeptidases (métabolisme)</term>
<term>Données de séquences moléculaires</term>
<term>Oligopeptides ()</term>
<term>Oligopeptides (pharmacologie)</term>
<term>Oligopeptides (synthèse chimique)</term>
<term>Protéines virales (antagonistes et inhibiteurs)</term>
<term>Protéines virales (métabolisme)</term>
<term>Séquence d'acides aminés</term>
<term>Virus du SRAS ()</term>
<term>Virus du SRAS (enzymologie)</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="antagonists & inhibitors" xml:lang="en"><term>Viral Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemical synthesis" xml:lang="en"><term>Enzyme Inhibitors</term>
<term>Oligopeptides</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en"><term>Antiviral Agents</term>
<term>Enzyme Inhibitors</term>
<term>Oligopeptides</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en"><term>Antiviral Agents</term>
<term>Cysteine Endopeptidases</term>
<term>Viral Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en"><term>Enzyme Inhibitors</term>
<term>Oligopeptides</term>
</keywords>
<keywords scheme="MESH" qualifier="antagonistes et inhibiteurs" xml:lang="fr"><term>Protéines virales</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en"><term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" qualifier="enzymologie" xml:lang="fr"><term>Virus du SRAS</term>
</keywords>
<keywords scheme="MESH" qualifier="enzymology" xml:lang="en"><term>SARS Virus</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr"><term>Antiviraux</term>
<term>Cysteine endopeptidases</term>
<term>Protéines virales</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr"><term>Antienzymes</term>
<term>Oligopeptides</term>
</keywords>
<keywords scheme="MESH" qualifier="synthèse chimique" xml:lang="fr"><term>Antienzymes</term>
<term>Oligopeptides</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Amino Acid Sequence</term>
<term>Animals</term>
<term>Chlorocebus aethiops</term>
<term>Molecular Sequence Data</term>
<term>Vero Cells</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Animaux</term>
<term>Antienzymes</term>
<term>Antiviraux</term>
<term>Cellules Vero</term>
<term>Données de séquences moléculaires</term>
<term>Oligopeptides</term>
<term>Séquence d'acides aminés</term>
<term>Virus du SRAS</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The outbreak of SARS, a life-threatening disease, has spread over many countries around the world. So far there is no effective drug for the treatment of SARS. Stimulated by the binding mechanism of SARS-CoV Mpro with the octapeptide AVLQSGFR reported recently as well as the "Chou's distorted key" theory, we synthesized the octapeptide AVLQSGFR for conducting various biochemical experiments to investigate the antiviral potential of the octapeptide against SARS coronavirus (BJ-01). The results demonstrate that, compared with other compounds reported so far, AVLQSGFR is the most active in inhibiting replication of the SARS coronavirus, and that no detectable toxicity is observed on Vero cells under the condition of experimental concentration.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">16242214</PMID>
<DateCompleted><Year>2006</Year>
<Month>08</Month>
<Day>11</Day>
</DateCompleted>
<DateRevised><Year>2020</Year>
<Month>04</Month>
<Day>07</Day>
</DateRevised>
<Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Print">0196-9781</ISSN>
<JournalIssue CitedMedium="Print"><Volume>27</Volume>
<Issue>4</Issue>
<PubDate><Year>2006</Year>
<Month>Apr</Month>
</PubDate>
</JournalIssue>
<Title>Peptides</Title>
<ISOAbbreviation>Peptides</ISOAbbreviation>
</Journal>
<ArticleTitle>Synthesis and activity of an octapeptide inhibitor designed for SARS coronavirus main proteinase.</ArticleTitle>
<Pagination><MedlinePgn>622-5</MedlinePgn>
</Pagination>
<Abstract><AbstractText>The outbreak of SARS, a life-threatening disease, has spread over many countries around the world. So far there is no effective drug for the treatment of SARS. Stimulated by the binding mechanism of SARS-CoV Mpro with the octapeptide AVLQSGFR reported recently as well as the "Chou's distorted key" theory, we synthesized the octapeptide AVLQSGFR for conducting various biochemical experiments to investigate the antiviral potential of the octapeptide against SARS coronavirus (BJ-01). The results demonstrate that, compared with other compounds reported so far, AVLQSGFR is the most active in inhibiting replication of the SARS coronavirus, and that no detectable toxicity is observed on Vero cells under the condition of experimental concentration.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Gan</LastName>
<ForeName>Yi-Ru</ForeName>
<Initials>YR</Initials>
<AffiliationInfo><Affiliation>School of Chemical Engineering & Technology, Tianjin University, Tianjin 300072, China. lifescience@san.rr.com</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Huang</LastName>
<ForeName>He</ForeName>
<Initials>H</Initials>
</Author>
<Author ValidYN="Y"><LastName>Huang</LastName>
<ForeName>Yong-Dong</ForeName>
<Initials>YD</Initials>
</Author>
<Author ValidYN="Y"><LastName>Rao</LastName>
<ForeName>Chun-Ming</ForeName>
<Initials>CM</Initials>
</Author>
<Author ValidYN="Y"><LastName>Zhao</LastName>
<ForeName>Yang</ForeName>
<Initials>Y</Initials>
</Author>
<Author ValidYN="Y"><LastName>Liu</LastName>
<ForeName>Jin-Sheng</ForeName>
<Initials>JS</Initials>
</Author>
<Author ValidYN="Y"><LastName>Wu</LastName>
<ForeName>Lei</ForeName>
<Initials>L</Initials>
</Author>
<Author ValidYN="Y"><LastName>Wei</LastName>
<ForeName>Dong-Qing</ForeName>
<Initials>DQ</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
<ArticleDate DateType="Electronic"><Year>2005</Year>
<Month>10</Month>
<Day>19</Day>
</ArticleDate>
</Article>
<MedlineJournalInfo><Country>United States</Country>
<MedlineTA>Peptides</MedlineTA>
<NlmUniqueID>8008690</NlmUniqueID>
<ISSNLinking>0196-9781</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D000998">Antiviral Agents</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D004791">Enzyme Inhibitors</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D009842">Oligopeptides</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D014764">Viral Proteins</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 3.4.22.-</RegistryNumber>
<NameOfSubstance UI="C099456">3C-like proteinase, Coronavirus</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>EC 3.4.22.-</RegistryNumber>
<NameOfSubstance UI="D003546">Cysteine Endopeptidases</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000595" MajorTopicYN="N">Amino Acid Sequence</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D000998" MajorTopicYN="N">Antiviral Agents</DescriptorName>
<QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002522" MajorTopicYN="N">Chlorocebus aethiops</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003546" MajorTopicYN="N">Cysteine Endopeptidases</DescriptorName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004791" MajorTopicYN="N">Enzyme Inhibitors</DescriptorName>
<QualifierName UI="Q000138" MajorTopicYN="Y">chemical synthesis</QualifierName>
<QualifierName UI="Q000737" MajorTopicYN="N">chemistry</QualifierName>
<QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008969" MajorTopicYN="N">Molecular Sequence Data</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009842" MajorTopicYN="N">Oligopeptides</DescriptorName>
<QualifierName UI="Q000138" MajorTopicYN="N">chemical synthesis</QualifierName>
<QualifierName UI="Q000737" MajorTopicYN="Y">chemistry</QualifierName>
<QualifierName UI="Q000494" MajorTopicYN="Y">pharmacology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D045473" MajorTopicYN="N">SARS Virus</DescriptorName>
<QualifierName UI="Q000187" MajorTopicYN="Y">drug effects</QualifierName>
<QualifierName UI="Q000201" MajorTopicYN="N">enzymology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014709" MajorTopicYN="N">Vero Cells</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D014764" MajorTopicYN="N">Viral Proteins</DescriptorName>
<QualifierName UI="Q000037" MajorTopicYN="Y">antagonists & inhibitors</QualifierName>
<QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="received"><Year>2004</Year>
<Month>09</Month>
<Day>14</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="revised"><Year>2005</Year>
<Month>09</Month>
<Day>09</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="accepted"><Year>2005</Year>
<Month>09</Month>
<Day>09</Day>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2005</Year>
<Month>10</Month>
<Day>26</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2006</Year>
<Month>8</Month>
<Day>12</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="entrez"><Year>2005</Year>
<Month>10</Month>
<Day>26</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">16242214</ArticleId>
<ArticleId IdType="pii">S0196-9781(05)00432-8</ArticleId>
<ArticleId IdType="doi">10.1016/j.peptides.2005.09.006</ArticleId>
<ArticleId IdType="pmc">PMC7115688</ArticleId>
</ArticleIdList>
<ReferenceList><Reference><Citation>Curr Med Chem. 2004 Aug;11(16):2105-34</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15279552</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Anal Biochem. 1996 Jan 1;233(1):1-14</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8789141</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Peptides. 2004 Nov;25(11):1857-64</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15501516</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Chem Inf Comput Sci. 2004 May-Jun;44(3):1111-22</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15154780</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Biol Chem. 1993 Mar 25;268(9):6119-24</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7681060</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Science. 2003 Jun 13;300(5626):1763-7</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12746549</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Proc Natl Acad Sci U S A. 2003 Nov 11;100(23):13190-5</Citation>
<ArticleIdList><ArticleId IdType="pubmed">14585926</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Biol Chem. 1993 Aug 15;268(23):16938-48</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8349584</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Biochem Biophys Res Commun. 1967 Apr 20;27(2):157-62</Citation>
<ArticleIdList><ArticleId IdType="pubmed">6035483</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Protein Chem. 1993 Jun;12(3):291-302</Citation>
<ArticleIdList><ArticleId IdType="pubmed">8397787</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>J Biol Chem. 1993 Jul 15;268(20):14875-80</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7686907</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Med Chem. 2005 May;1(3):209-13</Citation>
<ArticleIdList><ArticleId IdType="pubmed">16787316</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Lancet. 2003 Jun 14;361(9374):2045-6</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12814717</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Anal Biochem. 1994 Sep;221(2):217-30</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7529005</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Anal Biochem. 2005 Feb 15;337(2):262-70</Citation>
<ArticleIdList><ArticleId IdType="pubmed">15691506</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Biochemistry. 1993 Jul 6;32(26):6548-54</Citation>
<ArticleIdList><ArticleId IdType="pubmed">7687145</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Biochem Biophys Res Commun. 2003 Aug 15;308(1):148-51</Citation>
<ArticleIdList><ArticleId IdType="pubmed">12890493</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
<ReferenceList><Reference><Citation>Science. 1989 Dec 1;246(4934):1149-52</Citation>
<ArticleIdList><ArticleId IdType="pubmed">2686029</ArticleId>
</ArticleIdList>
</Reference>
</ReferenceList>
</PubmedData>
</pubmed>
<affiliations><list><country><li>République populaire de Chine</li>
</country>
<settlement><li>Tianjin</li>
</settlement>
</list>
<tree><noCountry><name sortKey="Huang, He" sort="Huang, He" uniqKey="Huang H" first="He" last="Huang">He Huang</name>
<name sortKey="Huang, Yong Dong" sort="Huang, Yong Dong" uniqKey="Huang Y" first="Yong-Dong" last="Huang">Yong-Dong Huang</name>
<name sortKey="Liu, Jin Sheng" sort="Liu, Jin Sheng" uniqKey="Liu J" first="Jin-Sheng" last="Liu">Jin-Sheng Liu</name>
<name sortKey="Rao, Chun Ming" sort="Rao, Chun Ming" uniqKey="Rao C" first="Chun-Ming" last="Rao">Chun-Ming Rao</name>
<name sortKey="Wei, Dong Qing" sort="Wei, Dong Qing" uniqKey="Wei D" first="Dong-Qing" last="Wei">Dong-Qing Wei</name>
<name sortKey="Wu, Lei" sort="Wu, Lei" uniqKey="Wu L" first="Lei" last="Wu">Lei Wu</name>
<name sortKey="Zhao, Yang" sort="Zhao, Yang" uniqKey="Zhao Y" first="Yang" last="Zhao">Yang Zhao</name>
</noCountry>
<country name="République populaire de Chine"><noRegion><name sortKey="Gan, Yi Ru" sort="Gan, Yi Ru" uniqKey="Gan Y" first="Yi-Ru" last="Gan">Yi-Ru Gan</name>
</noRegion>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Ncbi/Merge

HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 001222 | SxmlIndent | more

HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd -nk 001222 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    SrasV1
   |flux=    Ncbi
   |étape=   Merge
   |type=    RBID
   |clé=     pubmed:16242214
   |texte=   Synthesis and activity of an octapeptide inhibitor designed for SARS coronavirus main proteinase.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Merge/RBID.i   -Sk "pubmed:16242214" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Merge/biblio.hfd   \
       | NlmPubMed2Wicri -a SrasV1

This area was generated with Dilib version V0.6.33.
Data generation: Tue Apr 28 14:49:16 2020. Site generation: Sat Mar 27 22:06:49 2021

	Serveur d'exploration SRAS
	Attention, ce site est en cours de développement ! Attention, site généré par des moyens informatiques à partir de corpus bruts. Les informations ne sont donc pas validées.

Serveur d'exploration SRAS

Synthesis and activity of an octapeptide inhibitor designed for SARS coronavirus main proteinase.

Synthesis and activity of an octapeptide inhibitor designed for SARS coronavirus main proteinase.

Source :

Descripteurs français

English descriptors

Abstract

Links toward previous steps (curation, corpus...)

Links to Exploration step

Le document en format XML

Pour manipuler ce document sous Unix (Dilib)

Pour mettre un lien sur cette page dans le réseau Wicri

Pour générer des pages wiki